Microbot Medical (MBOT) Cash from Financing Activities (2010 - 2025)

Microbot Medical's Cash from Financing Activities history runs 13 years deep, the most recent figure standing at $2.5 million for Q4 2025.

• Quarterly Cash from Financing Activities fell 11.51% year-over-year to $2.5 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $86.2 million (up 986.69% YoY) and the FY2025 annual result came in at $86.2 million, up 986.69% from the prior year.
• Cash from Financing Activities was $2.5 million for Q4 2025 at Microbot Medical, down from $51.2 million in the prior quarter.
• Across five years, Cash from Financing Activities topped out at $51.2 million in Q3 2025 and bottomed at -$161000.0 in Q3 2023.
• A 3-year average of $10.4 million and a median of $2.5 million in 2025 frame the typical range for Cash from Financing Activities.
• Peak annual rise in Cash from Financing Activities reached 7984.68% in 2025, while the deepest fall reached 11.51% in 2025.
• Microbot Medical's Cash from Financing Activities stood at -$161000.0 in 2023, then jumped by 1859.01% to $2.8 million in 2024, then decreased by 11.51% to $2.5 million in 2025.
• Business Quant data shows MBOT's Cash from Financing Activities at $2.5 million in Q4 2025, $51.2 million in Q3 2025, and $4.8 million in Q2 2025.